EXHIBITION PREVIEW bioMerieux
As a world leader in microbiology for 60 years, bioMerieux is committed to major public health issues in the field of infectious diseases, such as antimicrobial resistance, respiratory infections and sepsis.
bioMerieux provides innovative end-to-end diagnostic solutions that improve patient outcomes, help prevent antimicrobial resistance and improve antimicrobial stewardship, as well as empowering clinicians and laboratorians in decision making by providing actionable data through integrated IT and DATA solutions.
www.biomerieux.com
Bruker’s latest advancement, the MALDI Biotyper IVD Software - MBT Compass HT IVD, offers unprecedented speed, processing up to 96 sample spots in just five minutes. The system’s performance is optimised by the fully automated IDealTune feature. New innovations include the MBT Mycobacteria IVD Kit and the MBT HT Filamentous Fungi IVD Module which features the user-friendly Mycelium Transfer (MyT) sample preparation procedure. These, coupled with a comprehensive reference library, ensure high success rates in microbial identification. Additionally, the MBT Sepsityper solution facilitates direct identification from positive blood cultures, along with resistance testing assays. Complementing these offerings is the IR Biotyper, leveraging FT-IR spectroscopy for rapid strain typing, particularly beneficial in hospital hygiene and epidemiology. Bruker’s MICRONAUT range of broth
bioMerieux. Bruker
Over a decade ago, Bruker revolutionised microbiology with the introduction of the market leading MALDI Biotyper. Now in its fourth generation, the MALDI Biotyper Sirius System sets a new standard with the addition of a negative ion mode, enabling rapid detection of colistin resistance through lipid analysis.
Bruker.
microdilution AST products delivers precise EUCAST MIC determination and detection of key resistance mechanisms. Bruker’s flagship brand for highly accurate single-drug MIC testing, UMIC, now features UMIC Cefiderocol. Bruker’s LiquidArray technology brings next generation multiplexing to the routine clinical microbiology laboratory for infectious disease diagnostics in the areas of mycobacteria and resistance detection and differentiation, and syndromic panels for gastrointestinal and sexually transmitted infections. High-quality workflows are offered with compatible nucleic acid extraction from patient sample to result.
www.bruker.com
Cepheid
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company’s GeneXpert systems and Xpert tests automate highly complex and time-consuming manual procedures, providing a better way for institutions of any size to perform world-
class PCR testing. Cepheid’s broad test portfolio spans
respiratory infections, blood virology, women’s and sexual health, TB and emerging infectious diseases, healthcare- associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings.
www.cepheid.com
Culture Collections (UKHSA). Cepheid. 24
Culture Collections (UKHSA) The UK Health Security Agency (UKHSA) is the custodian of four unique collections of expertly preserved, authenticated cell lines, bacteria, viruses and fungi of known provenance. The collections are developed, managed and maintained by highly trained, dedicated staff working in accordance with internationally recognised quality standards including certification to ISO 9001:2015. Scientists across the world use Culture Collections’ cell lines and microbial strains as controls for clinical diagnostic and antimicrobial susceptibility testing, food, water and environmental microbiology testing, quality control testing, validation studies, and in disease research and drug discovery. All bacterial and fungal strains are available in a freeze-dried format, in fused-glass ampoules. Viruses and cell lines are supplied as cryopreserved ampoules of living viruses/cells. Culture Collections also provides authenticated, quality controlled nucleic acids in a variety of formats. Nucleic acids are used increasingly in research and clinical diagnostic settings as an alternative to live microorganisms in disease research, as a means of producing vaccines, as a tool for identifying potential drug targets for novel therapeutics in drug development, and also as gene controls in diagnostic PCR assays. Culture Collections’ products and associated services support the scientific community with integrity, quality and expertise.
www.culturecollections.org.uk
APRIL 2024
WWW.PATHOLOGYINPRACTICE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57
